Some clinical experiences with the arylsulfonylureas in the management of diabetes mellitus.

Suppr

超能文献

作者信息

ERK V, HAAR H, MCGAVACK T H, SEEGERS W

出版信息

Metabolism. 1956 Nov;5(6 Part 2):919-32.

PMID:13378061

Abstract

摘要

相似文献

Some clinical experiences with the arylsulfonylureas in the management of diabetes mellitus.

Metabolism. 1956 Nov;5(6 Part 2):919-32.

The arylsulfonylureas and diabetes mellitus.

J Clin Endocrinol Metab. 1956 Dec;16(12):1626-8. doi: 10.1210/jcem-16-12-1626.

Metabolic studies with the arylsulfonylureas.

Metabolism. 1956 Nov;5(6 Part 2):953-63.

Metabolic studies with the arylsulfonylureas.

Diabetes. 1957 Jan-Feb;6(1):61; discussion, 62. doi: 10.2337/diab.6.1.61.

Sulfonylureas and diabetes mellitus. I. Clinical evaluation.

Diabetes. 1956 Sep-Oct;5(5):358-65. doi: 10.2337/diab.5.5.358.

Hypoglycaemic sulphonamides in the management of diabetes mellitus.

Australas Ann Med. 1957 May;6(2):105-12. doi: 10.1111/imj.1957.6.2.105.

[Experiences on 1,000 diabetics treated with sulfonylureas (BZ 55 and D 860)].

Gaz Med Fr. 1957 Mar 25;64(6):519-24.

[Diabetes chemotherapy].

Praxis. 1956 Oct 25;45(43):977-81.

[Oral therapy of diabetes].

Med Klin. 1956 Sep 7;51(36):1497-502.

Observations in diabetic subjects treated with sulfonylurea compounds.

Diabetes. 1957 Jan-Feb;6(1):64-7; discussion, 85-90. doi: 10.2337/diab.6.1.64.

引用本文的文献

Experience with glipasol (R. P. 2259)-an antidiabetic sulfonamide drug.

Can Med Assoc J. 1959 Jul 15;81(2):101-7.

Oral administration of orinase (tolbutamide); clinical observations of effect on nondiabetic and diabetic humans.

Calif Med. 1958 Feb;88(2):103-8.

The hypoglycaemic sulphonylureas.

Postgrad Med J. 1957 May;33(379):224-7. doi: 10.1136/pgmj.33.379.224.

Effect of iodine administration on thyroid function in diabetic patients.

Acta Diabetol Lat. 1984 Oct-Dec;21(4):357-60. doi: 10.1007/BF02582089.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Some clinical experiences with the arylsulfonylureas in the management of diabetes mellitus.

Metabolism. 1956 Nov;5(6 Part 2):919-32.

The arylsulfonylureas and diabetes mellitus.

J Clin Endocrinol Metab. 1956 Dec;16(12):1626-8. doi: 10.1210/jcem-16-12-1626.

Metabolic studies with the arylsulfonylureas.

Metabolism. 1956 Nov;5(6 Part 2):953-63.

Metabolic studies with the arylsulfonylureas.

Diabetes. 1957 Jan-Feb;6(1):61; discussion, 62. doi: 10.2337/diab.6.1.61.

Sulfonylureas and diabetes mellitus. I. Clinical evaluation.

Diabetes. 1956 Sep-Oct;5(5):358-65. doi: 10.2337/diab.5.5.358.

Hypoglycaemic sulphonamides in the management of diabetes mellitus.

Australas Ann Med. 1957 May;6(2):105-12. doi: 10.1111/imj.1957.6.2.105.

[Experiences on 1,000 diabetics treated with sulfonylureas (BZ 55 and D 860)].

Gaz Med Fr. 1957 Mar 25;64(6):519-24.

[Diabetes chemotherapy].

Praxis. 1956 Oct 25;45(43):977-81.

[Oral therapy of diabetes].

Med Klin. 1956 Sep 7;51(36):1497-502.

Observations in diabetic subjects treated with sulfonylurea compounds.

Diabetes. 1957 Jan-Feb;6(1):64-7; discussion, 85-90. doi: 10.2337/diab.6.1.64.

引用本文的文献

Experience with glipasol (R. P. 2259)-an antidiabetic sulfonamide drug.

Can Med Assoc J. 1959 Jul 15;81(2):101-7.

Oral administration of orinase (tolbutamide); clinical observations of effect on nondiabetic and diabetic humans.

Calif Med. 1958 Feb;88(2):103-8.

The hypoglycaemic sulphonylureas.

Postgrad Med J. 1957 May;33(379):224-7. doi: 10.1136/pgmj.33.379.224.

Effect of iodine administration on thyroid function in diabetic patients.

Acta Diabetol Lat. 1984 Oct-Dec;21(4):357-60. doi: 10.1007/BF02582089.